Freya Pharma Solutions to acquire all IP from Emotional Brain, giving opportunities to further examine pharmaceutical therapies for Female Sexual Interest/Arousal Disorder in a double blind, randomized phase 3 trial

AMSTERDAM, Dec. 17, 2021 /PRNewswire/ -- Freya Pharma Solutions, a late clinical stage biotech company focusing on the development of effective pharmaceutical therapies for women who have been

Related Keywords

United States ,Netherlands ,Amsterdam ,Noord Holland ,American ,Dutch ,Kostenloser Wertpapierhandel ,Freya Pharma ,American Psychiatric Association ,Prnewswire Freya Pharma Solutions ,Freya Pharma Solutions ,Lifespring Life Sciences Communication ,Pharma Solutions ,Female Sexual ,Arousal Disorder ,Dutch Emotional Brain ,Statistical Manual ,Mental Disorders ,Spring Life Sciences Communication ,Freya ,Dharma ,Solutions ,Cquire ,Rom ,Emotional ,Rain ,Diving ,Opportunities ,Urther ,Examine ,Harmaceutical ,Therapies ,Female ,Isexual ,Interest ,Arousal ,Disorder ,Double ,Blind ,Randomized ,Hase ,